Measles immunization — all countries

Measles immunization — Azerbaijan

Measles immunization in Azerbaijan in 2024 — 71%. Ranked 165 in the world out of 192. Since 1992, the indicator has risen by 19 pp.

2024 71% +0 pp vs 2023
World rank 165of 192
Period maximum 89%2010
Period minimum 49%1993

Trend over time

1992–2024 · % of children aged 12–23 months

Measles immunization — Azerbaijan, 1992–20244050607080901992199620002004200820122016202020241992: 52%1993: 49%1994: 60%1995: 64%1996: 65%1997: 66%1998: 67%1999: 68%2000: 67%2001: 68%2002: 66%2003: 67%2004: 67%2005: 67%2006: 69%2007: 75%2008: 79%2009: 85%2010: 89%2011: 88%2012: 86%2013: 86%2014: 85%2015: 84%2016: 81%2017: 80%2018: 77%2019: 78%2020: 61%2021: 66%2022: 71%2023: 71%2024: 71%
Change over the period: +19 pp Annual average: 0.59 pp

Comparison, 2024

How the value compares with the world and the groups this territory belongs to: Azerbaijan

Azerbaijan 71%
World 84.3%
Western Asia computed 85.4%
Measles immunization — Azerbaijan, by year Azerbaijan All countries CSV XLSX
Year % Change, pp
2024 71 +0 pp
2023 71 +0 pp
2022 71 +5 pp
2021 66 +5 pp
2020 61 −17 pp
2019 78 +1 pp
2018 77 −3 pp
2017 80 −1 pp
2016 81 −3 pp
2015 84 −1 pp
2014 85 −1 pp
2013 86 +0 pp
2012 86 −2 pp
2011 88 −1 pp
2010 89 +4 pp
2009 85 +6 pp
2008 79 +4 pp
2007 75 +6 pp
2006 69 +2 pp
2005 67 +0 pp
2004 67 +0 pp
2003 67 +1 pp
2002 66 −2 pp
2001 68 +1 pp
2000 67 −1 pp
1999 68 +1 pp
1998 67 +1 pp
1997 66 +1 pp
1996 65 +1 pp
1995 64 +4 pp
1994 60 +11 pp
1993 49 −3 pp
1992 52

About the indicator

The share of children aged 12–23 months who have been vaccinated against measles. Measles is more contagious than almost any other infection, and its threshold of herd immunity is higher than the rest — about 95% — so a fall in coverage by a few points brings outbreaks back to countries where the disease was considered beaten. This series shows how coverage sagged in 2020–2021 and where it has not recovered since.

Important: The first dose. Reliable protection requires two, and coverage of the second dose is lower; the World Bank has no separate series for it.

Source: Global Health Observatory (WHO), license CC BY-NC-SA 3.0 IGO.